Skip to main content
. 2021 Nov 17;65(12):e01105-21. doi: 10.1128/AAC.01105-21

TABLE 2.

Regional distribution of carbapenemase genes detected in carbapenem-resistant Enterobacterales, carbapenem-resistant Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii isolates and colonization screens according to the Antibiotic Resistance Laboratory Network, 2017 to 2019

Specimen type and regiona No. of specimens tested No. (%) of specimens with carbapenemase gene detectedb No. (%) of specimens with carbapenemase genec
bla KPC bla NDM bla VIM bla IMP bla OXA-48-like
Carbapenem-resistant Enterobacterales 42,006 14,562 (35) 12,540 (86) 1,378 (9) 117 (<1) 169 (1) 549 (4)
 Central 3,419 599 (18) 457 (76) 61 (10) (0) 50 (8) 36 (6)
 Mid-Atlantic 7,941 3,427 (43) 3,079 (88) 238 (7) 7 (<1) 18 (<1) 139 (4)
 Midwest 10,724 3,230 (30) 2,785 (86) 229 (7) 79 (2) 73 (2) 85 (3)
 Mountain 4,318 1,322 (31) 1,111 (83) 150 (11) 9 (<1) 9 (<1) 59 (4)
 Northeast 4,539 2,225 (49) 1,794 (81) 351 (16) 1 (<1) 4 (<1) 114 (5)
 Southeast 6,166 2,209 (36) 2,035 (91) 143 (6) 16 (1) 6 (<1) 39 (2)
 West 4,899 1,550 (32) 1,279 (81) 206 (13) 5 (<1) 9 (<1) 77 (5)
Carbapenem-resistant P. aeruginosa 30,390 672 (2) 171 (25) 47 (7) 414 (62) 56 (8) 0 (0)
 Central 3,370 23 (<1) 4 (17) 4 (17) 12 (50) 4 (17) 0 (0)
 Mid-Atlantic 3,122 50 (2) 27 (54) 7 (14) 13 (26) 3 (6) 0 (0)
 Midwest 5,445 49 (<1) 10 (20) 6 (12) 33 (66) 1 (2) 0 (0)
 Mountain 6,667 194 (3) 19 (10) 12 (6) 132 (67) 33 (17) 0 (0)
 Northeast 3,890 129 (3) 51 (40) 10 (8) 67 (52) 1 (<1) 0 (0)
 Southeast 3,838 154 (4) 58 (36) 3 (2) 97 (61) 2 (1) 0 (0)
 West 4,058 73 (2) 2 (3) 5 (6) 60 (76) 12 (15) 0 (0)
Carbapenem-resistant A. baumannii 4,491 39 (<1) 12 (31) 27 (69) 0 (0) 0 (0) 0 (0)
 Central 272 1 (<1) 1 (100) 0 (0) 0 (0) 0 (0) 0 (0)
 Mid-Atlantic 708 19 (3) 2 (11) 17 (89) 0 (0) 0 (0) 0 (0)
 Midwest 781 7 (<1) 2 (29) 5 (71) 0 (0) 0 (0) 0 (0)
 Mountain 1,369 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
 Northeast 320 3 (<1) 2 (67) 1 (33) 0 (0) 0 (0) 0 (0)
 Southeast 702 5 (<1) 2 (40) 3 (60) 0 (0) 0 (0) 0 (0)
 West 339 4 (1) 3 (75) 1 (25) 0 (0) 0 (0) 0 (0)
Colonization screens 31,001 2,503 (8) 2,103 (84) 281 (11) 205 (8) 5 (<1) 51 (2)
 Central 3,301 68 (2) 41 (60) 27 (40) 2 (3) 0 (0) 1 (1)
 Mid-Atlantic 4,998 632 (13) 575 (91) 37 (6) 11 (2) 5 (<1) 22 (3)
 Midwest 5,741 720 (13) 605 (84) 106 (15) 76 (11) 0 (0) 13 (2)
 Mountain 2,504 144 (6) 119 (83) 4 (3) 16 (11) 0 (0) 5 (3)
 Northeast 2,191 211 (10) 149 (71) 63 (30) 10 (5) 0 (0) 5 (2)
 Southeast 9,923 543 (5) 457 (84) 34 (6) 69 (13) 0 (0) 5 (<1)
 West 2,343 185 (8) 157 (85) 10 (5) 21 (11) 0 (0) 0 (0)
a

Antibiotic Resistance Laboratory Network Regions are as follows: Central, AR, IA, KS, MN, MO, ND, NE, OK, and SD; Mid-Atlantic, DC, DE, MD, NC, PA, Philadelphia, SC, VA, and WV; Midwest, IL, IN, KY, MI, OH, and WI; Mountain, AZ, CO, Houston, ID, MT, NM, TX, UT, and WY; Northeast, CT, MA, ME, NH, NJ, NY, New York City, RI, and VT; Southeast, AL, FL, GA, LA, MS, Puerto Rico, and TN; and West, AK, CA, HI, LA County, NV, OR, and WA.

b

Carbapenemase gene detected if PCR positive for ≥1 of the five targeted carbapenemase genes tested.

c

Genes are arranged by carbapenemase class; class B metallo-β-lactamase genes include blaNDM, blaVIM, and blaIMP. Specimens with multiple carbapenemase genes detected were counted once in each gene category.